BioCorRx (BICX) Total Non-Current Liabilities (2012 - 2024)

BioCorRx (BICX) has 10 years of Total Non-Current Liabilities data on file, last reported at $12.7 million in Q4 2024.

• Quarterly Total Non-Current Liabilities rose 23.85% year-over-year to $12.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $12.7 million (up 23.85% YoY) and the FY2024 annual result came in at $12.7 million, up 23.85% from the prior year.
• Total Non-Current Liabilities climbed to $12.7 million in Q4 2024 per BICX's latest filing, from $12.6 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $12.7 million in Q4 2024, with the low at $9.0 million in Q4 2022.
• Average Total Non-Current Liabilities over 3 years is $11.2 million, with a median of $11.3 million recorded in 2024.
• Year-over-year, Total Non-Current Liabilities grew 14.71% in 2023 and gained 23.85% in 2024.
• BioCorRx's Total Non-Current Liabilities stood at $9.0 million in 2022, then gained by 14.71% to $10.3 million in 2023, then gained by 23.85% to $12.7 million in 2024.
• Business Quant data shows BICX's Total Non-Current Liabilities at $12.7 million in Q4 2024, $12.6 million in Q3 2024, and $11.5 million in Q2 2024.